# Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)

> **NCT05643729** · PHASE1,PHASE2 · SUSPENDED · sponsor: **ZEO ScientifiX, Inc.** · enrollment: 20 (estimated)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Zofin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05643729
- **Lead sponsor:** ZEO ScientifiX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-11-15
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-08-31
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Study is on hold
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05643729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05643729, "Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05643729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*